美国FDA生物制品紫皮书数据库
(U.S. FDA Purple Book: Database of Licensed Biological Products)
商品名 申请号 产品号 BLA类型 非专利名称 剂型 给药途径 规格/剂量 产品形式 批准日期 申请人 市场状态 许可证状态 参考产品非专利名称 参考产品专利名称
Norditropin 021148 006 351(a) somatropin Injection Subcutaneous 15MG/1.5ML Autoinjector 2004/10/01 Novo Nordisk Inc. Disc Licensed N/A N/A
Enbrel 103795 003 351(a) etanercept Injection Subcutaneous 50MG/ML Pre-Filled Syringe 2004/09/27 Immunex Corporation Rx Licensed N/A N/A
Synagis 103770 003 351(a) palivizumab Injection Intramuscular 50MG/0.5ML Single-Dose Vial 2004/07/23 Swedish Orphan Biovitrum AB (publ) Rx Licensed N/A N/A
Synagis 103770 004 351(a) palivizumab Injection Intramuscular 100MG/1ML Single-Dose Vial 2004/07/23 Swedish Orphan Biovitrum AB (publ) Rx Licensed N/A N/A
NeutroSpec 103928 001 351(a) technetium 99m tc fanolesomab Injection Intravenous 0.25MG Single-Dose Vial 2004/07/02 Palatin Technologies, Inc. Disc Voluntarily Revoked N/A N/A
Jeanatope 017836 003 351(a) iodinated I-125 albumin Injection Intravenous 100uCi/10ML (10uCi/ML) Multi-Dose Vial 2004/06/08 Iso-Tex Diagnostics, Inc. Disc Voluntarily Revoked N/A N/A
Pegasys Copegus Combination Pack 125083 001 351(a) peginterferon alfa-2a and ribavirin 180MCG/0.5ML & 800MG 2004/06/04 Hoffmann-La Roche Inc. Disc Voluntarily Revoked N/A N/A
Pegasys Copegus Combination Pack 125083 002 351(a) peginterferon alfa-2a and ribavirin 180MCG/0.5ML &1000MG 2004/06/04 Hoffmann-La Roche Inc. Disc Voluntarily Revoked N/A N/A
Pegasys Copegus Combination Pack 125083 003 351(a) peginterferon alfa-2a and ribavirin 180MCG/0.5ML & 1200MG 2004/06/04 Hoffmann-La Roche Inc. Disc Voluntarily Revoked N/A N/A
Gonal-f RFF RediJect 021684 001 351(a) follitropin alfa Injection Subcutaneous 300IU/0.5ML Autoinjector 2004/05/25 EMD Serono, Inc. Rx Licensed N/A N/A
Gonal-f RFF RediJect 021684 002 351(a) follitropin alfa Injection Subcutaneous 450IU/0.75ML Autoinjector 2004/05/25 EMD Serono, Inc. Rx Licensed N/A N/A
Gonal-f RFF RediJect 021684 003 351(a) follitropin alfa Injection Subcutaneous 900IU/1.5ML Autoinjector 2004/05/25 EMD Serono, Inc. Rx Licensed N/A N/A
Octagam 125062 001 351(a) Immune Globulin Intravenous (Human) Injection Intravenous 5% 5.0G Single-Use Bottle 2004/05/21 Octapharma Pharmazeutika Produktionsges.m.b.H. Rx Licensed N/A
Octagam 125062 002 351(a) Immune Globulin Intravenous (Human) Injection Intravenous 5% 1.0G Single-Use Bottle 2004/05/21 Octapharma Pharmazeutika Produktionsges.m.b.H. Rx Licensed N/A
Octagam 125062 003 351(a) Immune Globulin Intravenous (Human) Injection Intravenous 5% 10G Single-Use Bottle 2004/05/21 Octapharma Pharmazeutika Produktionsges.m.b.H. Rx Licensed N/A
Octagam 125062 004 351(a) Immune Globulin Intravenous (Human) Injection Intravenous 5% 2.5G Single-Use Bottle 2004/05/21 Octapharma Pharmazeutika Produktionsges.m.b.H. Rx Licensed N/A
Vitrase 021640 001 351(a) hyaluronidase Injection Infiltration, Interstitial, Intramuscular, Intraocular, Peribulbar, Retrobulbar, Soft Tissue, Subcutaneous 6,200UNITS/ML Single-Dose Vial 2004/05/05 Bausch & Lomb Incorporated Disc Licensed N/A N/A
Novolog 020986 004 351(a) insulin aspart Injection Subcutaneous 300UNITS/3ML (100UNITS/ML) Autoinjector 2004/04/23 Novo Nordisk Inc. Disc Licensed N/A N/A
Apidra 021629 001 351(a) insulin glulisine Injection Intravenous, Subcutaneous 1,000UNITS/10ML (100UNITS/ML) Multi-Dose Vial 2004/04/16 Sanofi-Aventis U.S. LLC Rx Licensed N/A N/A
Gonal-f 020378 005 351(a) follitropin alfa For Injection Subcutaneous 450IU (600IU/ML) Multi-Dose Vial 2004/03/26 EMD Serono, Inc. Rx Licensed N/A N/A
当前数据更新日期:2025年12月18日,更多信息请点击此处查询美国FDA药品数据库

数据库说明:

©2006-2025 DrugFuture->U.S. FDA Purple Book